Literature DB >> 20649909

A study of atypical APTT derivative curves on the ACL TOP coagulation analyser.

C Solano1, P Zerafa, R Bird.   

Abstract

INTRODUCTION: The graphical representation of clotting data can provide useful information. A novel feature of the ACL TOP software allows display of clot reaction curves with superimposed first and second derivative curves. We noted atypical derivative plots associated with normal 'S'-shaped clot reaction curves in some abnormal activated partial thromboplastin time (APTT).
METHODS: We tested 179 citrate plasmas with four different APTT reagents on the ACL TOP. We documented the prevalence and utility of these APTT atypical derivative curves in these patients.
RESULTS: Ellagic acid APTT reagents commonly produce atypical derivative curves despite normal 'S'-shaped clot reaction curves. Occasionally, these atypical second derivative curves may cause incorrect APTT results. With silica activator APTT reagents, atypical derivative curves were associated with genuine coagulation abnormalities such as single factor deficiencies and lupus anticoagulants (LAs). To our knowledge, this novel finding has not been reported.
CONCLUSION: Atypical derivative curves seen in ellagic acid APTTs are of limited diagnostic use because of the frequency with which they occur. This may be related to the need to optimize the data reduction utilized on the ACL TOP for these reagents. With silica activator APTTs, the presence of atypical derivative curves proved to be a very simple tool when troubleshooting unexpected abnormal APTT results, commonly predicting a factor deficiency or LA that would warrant further investigation. The cause of these aberrant derivative curves is probably related to abnormal thrombin generation in the APTT test and warrants further study.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20649909     DOI: 10.1111/j.1751-553X.2010.01248.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  12 in total

1.  A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity.

Authors:  Tomoko Matsumoto; Keiji Nogami; Midori Shima
Journal:  Int J Hematol       Date:  2016-10-11       Impact factor: 2.490

2.  Differences in the Composition of Activated Partial Thromboplastin Time (APTT) Reagents Affect Clot Waveform Analysis.

Authors:  Konami Kato; Yuki Hatayama; Hisashi Shimohiro; Hitomi Ichikawa; Tetsuya Fukuda
Journal:  Yonago Acta Med       Date:  2022-08-29       Impact factor: 1.371

3.  Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab.

Authors:  Marina Di Pino; Maria Filomena Ruberto; Giulia Costanzo; Davide Firinu; Maria Sebastiana Piras; Mario Nicola Mura; Stefano Del Giacco; Ferdinando Coghe; Francesco Marongiu; Doris Barcellona
Journal:  Clin Exp Med       Date:  2022-05-25       Impact factor: 5.057

4.  An Evaluation of the Activated Partial Thromboplastin Time Waveform.

Authors:  Takeshi Matsumoto; Hideo Wada; Naoki Fujimoto; Junki Toyoda; Yasunori Abe; Kohshi Ohishi; Yoshiki Yamashita; Makoto Ikejiri; Kei Hasegawa; Kei Suzuki; Hiroshi Imai; Kaname Nakatani; Naoyuki Katayama
Journal:  Clin Appl Thromb Hemost       Date:  2017-09-08       Impact factor: 2.389

5.  Utility of Clot Waveform Analysis in Russell's Viper Bite Victims with Hematotoxicity.

Authors:  Siju V Abraham; Aboobacker Mohamed Rafi; S Vimal Krishnan; Babu Urumese Palatty; Susheela J Innah; Jerry Johny; Salish Varghese
Journal:  J Emerg Trauma Shock       Date:  2018 Jul-Sep

6.  Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk.

Authors:  Kei Suzuki; Hideo Wada; Takeshi Matsumoto; Makoto Ikejiri; Kohshi Ohishi; Yoshiki Yamashita; Hiroshi Imai; Toshiaki Iba; Naoyuki Katayama
Journal:  Thromb J       Date:  2019-06-28

7.  Clot waveform of APTT has abnormal patterns in subjects with COVID-19.

Authors:  Takuya Shimura; Makoto Kurano; Yoshiaki Kanno; Mahoko Ikeda; Koh Okamoto; Daisuke Jubishi; Sohei Harada; Shu Okugawa; Kyoji Moriya; Yutaka Yatomi
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

8.  Usefulness of the second-derivative curve of activated partial thromboplastin time on the ACL-TOP coagulation analyzer for detecting factor deficiencies.

Authors:  Naoki Tokunaga; Chihiro Inoue; Toshiyuki Sakata; Kumiko Kagawa; Masahiro Abe; Norimichi Takamatsu; Takayuki Nakao; Toshio Doi
Journal:  Blood Coagul Fibrinolysis       Date:  2016-06       Impact factor: 1.276

9.  Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis.

Authors:  Tatiana Koudriavtseva; Annunziata Stefanile; Marco Fiorelli; Caterina Lapucci; Svetlana Lorenzano; Silvana Zannino; Laura Conti; Giovanna D'Agosto; Fulvia Pimpinelli; Enea Gino Di Domenico; Chiara Mandoj; Diana Giannarelli; Sara Donzelli; Giovanni Blandino; Marco Salvetti; Matilde Inglese
Journal:  Front Immunol       Date:  2020-10-27       Impact factor: 7.561

10.  Update on the Clot Waveform Analysis.

Authors:  Hideo Wada; Takeshi Matsumoto; Kohshi Ohishi; Katsuya Shiraki; Motomu Shimaoka
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.